Gov. Mikie Sherrill told the pharmaceutical drug industry she would tackle rising drug prices by reining in the middlemen — pharmacy benefit managers.

To date, every court that has considered substantive challenges to the Medicare drug price negotiation program has ruled ...

The pharmaceutical industry has expressed strong opposition to the government’s push for drug price reductions, warning that such a policy—combined with rising oil prices, exchange rates, raw material ...

Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but prescription stockpiles are limited.

The major pharmas are loaded up with trillions in firepower—but are sticking to mid-cap deals. One expert says it might be ...

The U.S. Federal Trade Commission is vigilantly monitoring pharmaceutical companies as significant patent cliffs approach, aiming to protect consumers from unfair pricing. Meanwhile, R1 Therapeutics ...

Prime biotech buyout targets such as Revolution Medicines and Ascendis Pharma have recently found themselves in the middle of acquisition rumors—though no deals have panned out so far.

Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry giants last year are poised to make further advances in 2026, the chairman ...

The reason many cannabis companies avoided the pharmaceutical pathway for so long is simple: it is extraordinarily difficult. In fact, since the FDA first issued Botanical Drug Development Guidance in ...

And a lot of it has come from the pharmaceutical and medical companies.” Eddie O’Gara is my cousin. The farm he works and lives on is the same one my grandfather, Timothy Shannon, was born on in 1884, ...

FIRST ON FOX: Shortly after announcing a strategy to go after deceptive direct-to-consumer advertising by the pharmaceutical industry, Robert F. Kennedy Jr. and the Department of Health and Human ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.